TWENTY-SIXTH ANNUAL CONFERENCE ON SHOCK

Pointe Hilton Tapatio Cliffs Resort,

Phoenix, Arizona

June 7-10, 2003

FINAL PROGRAM

SATURDAY, June 7, 2003
8:00 AM-2:00 PM
Courtroom P
COUNCIL MEETING
12:00 - 6:00 PM
Ballroom Foyer
Registration
1:30 -1:40 PM
Salon ABCD
Welcome and Introduction
Kathleen McDonough, PhD, Louisiana State University Health Sciences Center, New Orleans, LA
1:45 - 2:45 PMPLENARY SESSION I Insights Into Immune Modulation During Sepsis and Burn Injury, Papers 1-4
Moderator: Alfred Ayala, PhD, Brown University School of Medicine, Providence, RI
1:45-2:00 PMAssociation of RLT4 Genotype with Increased Risk of Severe Sepsis and Septic Shock Following Thermal Injury, Paper 1
Robert C. Barber, PhD, University of Texas Southwestern Medical Center at Dallas, Dallas, TX
2:00-2:15 PMA Role for CD1d-Restricted Natural Killer Cells in Burn-Induced Immune Dysfunction, Paper 2
Douglas E. Faunce, PhD, Loyola University Medical Center, Maywood, IL
2:15-2:30 PMCharacterization of the Decreased Dendritic Cell Population in Murine Lymph Nodes During Polymicrobial Sepsis, Paper 3
Philip A. Efron, MD, University of Florida, Gainesville, FL
2:30-2:45 PMFactors Responsible for Suppressor of Cytokine Signaling (SOCS)-3 Upregulation in Polymicrobial Sepsis is Site-Specific, Paper 4
Patricia S. Grutkoski, PhD, Rhode Island Hospital/Brown University School of Medicine, Providence, RI
2:45- 5:15 PM
Salon ABCD
WORKSHOP I: Immunoresuscitation: The Immune Effects of Resuscitation Fluids
Moderator: Carl Hauser, MD, University School of Medicine and Dentistry of New Jersey, Newark, NJ
2:45-3:10 PMThe Inflammatory Effects of Asanguinous Fluids
Peter Rhee, MD, University of Southern California, Los Angeles, CA
Resuscitation fluids can cause inflammation. This talk will provide an overview of the differential effects of commonly used resuscitation fluids on inflammation. Hypo and isotonic crystalloids as well as artificial colloids can elicit immune activation and cellular injury whereas plasma, albumin and fresh blood do not. Hypertonic fluids may suppress inflammation by preserving cellular structure. Controlling resuscitation may prevent immune dysfunction better than trying to reverse established cellular injury.
3:10-3:35 PMThe Immune Effects of Osmolarity
Ori Rotstein, MD, University of Toronto, Toronto General Hospital, Toronto, Canada
This presentation will review the cellular and molecular mechanisms that underlie the effects of hyperosmolar solutions on immune cell function and will discuss in-vivo models wherein hypertonic solutions have been shown to have immune modulatory effects.
3:35-4:00 PMThe Immune Effects of Oxygen Carrying Solutions
Ernest E. Moore, MD, Denver Health Medical Center
Blood transfusions have immune effects that range from transplant and tumor tolerance to increased risks for infection after trauma. Blood products can contain inflammatory cytokines or lipids that prime PMNs and participate in ARDS. This presentation will discuss evolving concepts of the role of transfusion in the pathophysiology of organ failure.
4:00-4:25 PMThe Immune Effects of Colloid Resuscitation
Oliver Kempski, MD, Institute for Neurosurgical Pathophysiology, Johannes Gutenberg-University Mainz, Mainz, Germany
This presentation will give an overview of the effects of colloids (albumin as well as artificial colloids) on leukocyte-endothelial interactions and on the immunology of shock and ischemia. In addition it will review published results and current research on 1) the effects of albumin on the mesenteric microcirculation after hemorrhagic shock in rats and 2) the effects of hypertonic/hyperoncotic treatment upon focal and global cerebral ischemia.
4:25-4:50PMThe Clinical Uses of Hypertonic Fluids
David Hoyt, MD, University of California San Diego, San Diego, CA
The opportunity to modulate the immune responses to trauma and shock by means of their initial fluid resuscitation has great clinical potential. Laboratory observations to date are compelling, but they only represent phenomenology unless true clinical benefit can be demonstrated. This presentation will draw upon basic laboratory observations regarding the effects of fluid resuscitation on immune function, review the clinical studies of hypertonic fluids done to date, and define the clinical parameters and studies that need to be done to support their clinical use in the future.
4:50-5:15 PMClosing Discussion and Questions (Dr. Hauser and panel)
This program is supported by an unrestricted educational grant from Aventis Behring.
7:30 - 8:30 PM
Salon ABCD
Presidential Keynote Address
David Hoyt, MD University of California, San Diego
8:30 - 9:30 PM
Grotto Pool
WELCOME RECEPTION

 

SUNDAY, June 8, 2003
7:00 - 8:00 AM
Pavillion
Continental Breakfast
7:00 - 9:00 AM
Courtroom MN
EDITORIAL BOARD BREAKFAST (Invitation only)
7:00 - 10:00 AM
Pavillion
POSTER SESSION I: Papers 5-71
Adhesion Molecules, Papers 5-6
Animal Models, Papers 7-11
Burn/Trauma, Papers 12-36
Cell Signaling, Papers 37-49
Cellular/Molecular, Papers 50-58
Clinical Applications, Papers 59-60
Cytokines, Papers 61-69
Eicosanoids/PAF, Papers 70-71
10:00 AM - 12:00
Salon ABCD
SYMPOSIUM I Genes and Shock Research
Moderator: Gregory Bagby, PhD
Louisiana State University Health Sciences Center, New Orleans, LA
Speakers will discuss the role of genes in the response to injury and changes in gene expression in inflammation, sepsis and shock as assessed by analysis of gene expression by microarray techniques. The pros and cons of using transgenic and knockout animals to investigate mechanisms of injury and protection from injury will be presented. How variants of gene expression and polymorphisms impact the response to stressors and finally, the therapeutic potential of gene therapy will be presented.
10:00-10:25 AMWhat Can We Learn from Micorarray Analysis?
J. Perren Cobb, MD, Washington University, St. Louis, MO
10:25-10:50 AMUse of Transgenic Animals in Research
Klaus Ley, MD, University of Virginia, Charlotte, VA
10:50-11:15 AMPolymorphisms - How Do They Affect the Response to Inflammation and Injury
Grant O'Keefe, MD, University of Washington, Seattle, WA
11:15-11:40 AMGene Therapy in Shock
Lyle Moldawer, PhD, University of Florida, Gainesville, FL
11:40-12:00 PMPanel Discussion and Questions
10:30 - 11:00 AM
Ballroom Foyer
Coffee Break
12:00-1:30 PM
Salon GHIJ
LUNCH
12:00 - 1:30 PM
Pavillion
Poster Discussion Session for New Investigators, moderated by Daniel Remick, MD, University of Michigan, Ann Arbor, MI
1:45-3:00 PM
Salon ABCD
New Investigator Competition (papers 72-76)
Moderator: H. Hank Simms, MD, North Shore University Hospital, Manhasset, NY
1:45-2:00 PMToll-Like Receptor 4 (TLR4) Coupled GI Protein Signaling Pathways Activate Extracellular Signal-Regulated Kinase (ERK1/2) Phosphorylation Independent of NFkB Activation. Paper 72
Hongkuan Fan, PhD, The Medical University of South Carolina, Charleston, SC
2:00-2:15 PMOxidants in Hemorrhagic Shock Induce Lipid Raft Recruitment of Toll Like Receptor-4 (TLR-4). Paper 73
Kinga Powers, MD, University of Toronto, Toronto General Hospital, Toronto, Ontario, Canada
2:15-2:30 PMBCL-2 Inhibits Gut Epithelial Apoptosis but Does Not Improve Survival in Acute Lung Injury. Paper 74
Kareem D. Husain, MD, Washington University, St. Louis, MO.
2:30-2:45 PMAgeing and Caloric Restricted Diet Are Confounding Factors that Alter the Response to LPS by Peritoneal Macrophages from C57BL/6 Mice. Paper 75
Virginia L. Vega, PhD, Johns Hopkins University School of Medicine, Baltimore, MD
2:45-3:00 PMModulation of Mitochondria-Dependent Neutrophil Apoptosis With Burn Injury. Paper 76
Zhihong Hu, MD, Loyola University Medical Center, Maywood, IL.
The New Investigator Competition is supported by an unrestricted educational gift from Pharmacia/Pfizer
3:00-3:30 PM
Ballroom Foyer
Coffee Break
3:30-5:30 PM
Salon ABCD
Mini-Symposium I: Organ Injury and Mechanisms of Protection (Papers 77-86)
Moderators: R. Wayne Barbee, PhD, Virginia Commonwealth University, Richmond, VA; Susan Stern, MD, University of Michigan, Ann Arbor, MI
3:30-3:42 PMPreliminary Studies Using Near Ultraviolet Excitation Fluorescence Spectroscopy to Monitor Tissue Dysoxia During Hemorrhage. Paper 77
R.Wayne Barbee, Virginia Commonwealth University, Richmond, VA.
3:42-3:54 PMStarling Curve Generation During Shock Resuscitation: Can It be Done? Paper 78
Alan.B. Marr, University of Texas-Houston Medical School, Memorial Hermann Hospital STICU, Houston, TX
4:18-4:30 PMLipopolysaccharide-Binding Protein Modulates Hepatic Damage and lnflammatory Response After Hemorrhagic Shock and Resuscitation. Paper 81
Mark Lehnert, University of North Carolina, Chapel Hill, NC
4:30-4:42 PMIL-6 Plays A Major Role in Producing Hepatic Injury Following Trauma-Hemorrhage. Paper 82
Balazs Toth, University of Alabama at Birmingham, Birmingham, AL.
4:42-4:54 PMGlucagon Decreases Hepatic iNOS Synthesis In Vivo. Paper 83
Brian.G.Harbrecht, MD, University of Pittsburgh, Pittsburgh, PA
4:54- 5:06 PMRapid Suppression of the LPS-Induced TNF Response by Physical Exercise and Ether Stress Through a B2-Adrenergic Mechanism. Paper 84
Gregory J. Bagby, Louisiana State University Health Sciences Center, New Orleans, LA
5:06-5:18 PMAttenuation of Local and Systemic Acute Inflammation by Acupuncture: Evidence for Cholinergic and Vagal Involvements. Paper 85
Shi Ping Zhang, School Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, PRC
5:18-5:30 PMGlutamine Attenuates the Metabolic Dysfunction of Sublethal Endotoxin Shock Via Manipulation of the Heat Stress Protein Pathway. Paper 86
Kristen D. Singleton, University of Colorado Health Sciences Center, Denver, CO
3:30-5:30 PM
Salon EF
Mini-Symposium II: Intracellular Signaling and Gene Expression (Papers 87-96)
Moderators: Thomas Vary, PhD, Pennsylvania State College of Medicine, Hershey, PA and Linda Vona-Davis, PhD, Robert C. Byrd Health Science Center, Morgantown, WV
3:30-3:42 PMSepsis-Induced Muscle Growth Hormone Resistance Occurs Independent of STAT Phosphorylation. Paper 87
Charles H. Lang, Pennsylvania State College of Medicine, Hershey, PA.
3:42-3:54 PMNicotine Enhances Endothelial Cell (EC) Adhesion Molecule Expression Via p38 Mitogen Activated Protein Kinase (MAPK). Paper 88
Hirokazu Ueno, Chiba University Graduate School of Medicine, Chiba, Japan.
3:54-4:06 PMFluorescence Resonance Energy Transfer (FRET) Analysis of Hypertonic Interference With Postendocytotic Inflammatory Signaling in Human Cells. Paper 89
Anirban Banerjee, University of Colorado, Denver, CO
4:06-4:18 PMHyposia Disrupts iNOS Interaction with Alpha-Actinin 4 and Changes its Cellular Localization in Mouse Macrophages. Paper 90
Haim Bitterman, Carmel Medical Center, Faculty of Medicine, Technion, Haifa, Israel.
4:18-4:30 PMDifferential Role of p38 And ERK 1/2 MAP Kinases in the Induction of Macrophage Hyperactivity Following Burn Trauma. Paper 91
Martin G. Schwacha, University of Alabama at Birmingham, Birmingham, AL.
4:30-4:42 PMOsmotic Stress Increases Phosphatidyl-Inositol 4,5 Bisphosphate (PIP2) Synthesis. Paper 92
Helen L.Yin, University of Texas, Southwestern Medical Center, Dallas, TX.
4:42-4:54 PMP-Glycoprotein is Upregulated by Hypoxic Stress in Enterocytes During Intestinal Inflammation. Paper 93
Faisal G. Qureshi, Children's Hospital of Pittsburgh, Pittsburgh, PA
4:54-5:06 PMDifferential Gene Expression in Blood Leukocytes After LPS Administration to Human Volunteers: Effect of RNA Isolation Methods. Paper 94
Steve E. Calvano, (Inflammation and Host Response to Injury Large Scale Collaborative Research Program) UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
5:06-5:18 PMGene Expression Profiles in Endotoxin-Tolerant Mouse Macrophages. Paper 95
Jianjun J. Gao, School of Medicine, University of Missouri, Kansas City, MO
5:18-5:30 PMSeverity of Hemorrhagic Shock-Induced RBC Damage in Females Depends on the Stage of Estrus Cycle. Paper 96
Sergey Zaets, UMDNJ-New Jersey Medical School, Newark, NJ
5:45-6:30 PM
Grotto Pool
Reception for New Members/Travel Awardees/NIC (Invitation only)
6:30-7:30 PM
East Courtyard
Reception
7:30-9:30 PM
Salon GHIJ
Dinner/NIC & Travel Awards Ceremony

 

MONDAY, June 9, 2003
6:00 - 7:00 AM
Hotel Lobby
Annual Presidential Run
7:00 - 8:00 AM
Pavillion
Continental Breakfast
7:00 - 10:00 AM
Pavillion
POSTER SESSION II Papers 97-178
Endotoxin/Sepsis, Papers 97-128
Gene Regulation, Papers 129-132
Hemorrhagic Shock, Papers 133-178
10:00 - 12:00 PM
Salon ABCD
SYMPOSIUM II: -Endotoxin Tolerance; from Bench to Bedside
Moderator, James Cook, PhD, Medical University of South Carolina, Charleston, SC; co-moderator, Basilia Zingarelli, MD, PhD, University of Cincinnati, Cincinnati, OH
Pretreatment with low concentrations of bacterial endotoxin induces resistance to subsequent lethal endotoxin challenge and re-programs macrophage/monocyte pro-inflammatory/anti-inflammatory mediator expression. This phenomenon, known as endotoxin tolerance, has been linked to multiple alterations in toll-like receptor signaling pathways. Experimentally, endotoxin tolerance can induce cross tolerance to other microbial products, and cross tolerance to ischemia/reperfusion injury. However there is also speculation that tolerance may be linked to immunoparalysis in SIRs patients and susceptibility to nosocomial infections. This symposium will address recent advances in molecular mechanisms of endotoxin tolerance, mechanisms of ischemia/reperfusion cross-tolerance, and the potential clinical relevance of this phenomenon in critically ill patients.
10:00-10:20 AMPerspectives on Endotoxin Tolerance
James Cook, PhD Medical University of South Carolina, Charleston, SC
10:20-10:40 AMCardiac Tolerance: A Crossword Puzzle
Xianzhong Meng, MD, University of Colorado Health Sciences Center, Denver, CO
10:40-11:00 AMIs Tolerance Tolerable?
Michael West, MD, PhD, Northwestern University, Chicago, IL
11:00-11:20 AMEndotoxin Tolerance: is There Clinical Relevance?
Jean-Marc Cavaillon, Dr. Sc., Institut Pasteur, Paris, France
11:20-11:30 AMKey Issues in Endotoxin Tolerance
Basilia Zingarelli, MD, PhD, University of Cincinnati, Cincinnati, OH
11:30-12:00 PMPanel Discussion and Questions
10:30 - 11:00 AM
Ballroom Foyer
Coffee Available
12:00 - 1:00 PM
Salon ABCD
BUSINESS MEETING
FREE AFTERNOON
1:00 - 8:00 PMSPECIAL SESSION
The Glue Grant will hold an afternoon meeting in conjunction with the annual Shock Society Meeting. The Glue Grant meeting will be held during the free afternoon on Monday, June 9, 2003. The first portion of the meeting will be open to the public.
1:00 - 3:00 PMOverview and brief progress reports (open meeting)
3:00 - 6:00 PMBreakout sessions for scientific cores (closed meeting)
6:00 - 8:00 PMBreakout session reports and dinner (closed meeting)

 

TUESDAY, June 10, 2003
7:00 - 8:00 AM
Pavillion
Continental Breakfast
7:00 - 10:00 AM
Pavillion
POSTER SESSION III: Papers 179-261
Immunologic Dysfunction, Papers179-183
Immunomodulation, Papers 184-192
Inflammation, Papers 193-203
Ischemia/Reperfusion, Papers 204-212
Liver, Papers 213-214
Metabolism, Papers 215-219
Microcirculation, Papers 220-225
Monocytes/Macrophages, Papers 226-229
Multiple Organ Failure, Papers 230-232
Myocardial Function, Papers 233-235
Neural Aspects, Papers, 236-237
Neutrophils, Papers 238-242
Nitric Oxide, Papers 243-249
Oxygen Metabolites, Paper 250
Pharmacologic Agents, Papers 251-254
Pulmonary, Papers 255-259
Other, Papers 260-261
10:00 - 12:00 PM
Salon ABCD
SYMPOSIUM III: Magic Bullets - What are the Most Reasonable Targets for Drug Therapy?
Moderator, Daniel Remick, MD, University of Michigan, Ann Arbor, MI; co-moderator, Nicole Gibran, MD, University of Washington, Seattle, WA
This symposium will focus on therapies for the treatment of sepsis or thermal injury. Most of the participants are aware of the numerous therapies that have failed in the past for the treatment of these conditions. A range of presentations will be made, which include identification of specific potential modulators of the inflammatory response as well as a broader view of the approach to identifying those factors which result in organ injury and death. Additionally, the roles of the neuro immune system and specific cellular dysfunction will be presented. It is hope that this symposium will present information, which is both cutting-edge as well as informative.
10:00-10:25 AMThe Inflammatory Reflex
Kevin Tracey, MD, North Shore University Hospital, Cornell University Medical College, Manhasset, NY
10:25-10:50 AMSystematic Approach to the Investigation of the Mediators of Sepsis
Ronald Tompkins, MD, Massachusetts General Hospital, Harvard Medical School, Boston, MA
10:50-11:15 AMInhibition of Lymphocyte Death in Sepsis: a New Therapeutic Strategy?
Richard Hotchkiss, MD, Washington University, St. Louis, MO
11:15-11:40 AMModulation of Lyn/Erk or Ca2+ Signaling Attenuates PMN Superoxide Generation
Mohammed Sayeed, PhD, Loyola University, Chicago, IL
11:40-12:00 PMPanel Discussion and Questions
10:30 - 11:00 AM
Ballroom Foyer
Coffee Available
12:00 - 1:30 PM
Salon GHIJ
LUNCH
1:30 - 3:30 PM
Salon ABCD
WORKSHOP II: Good Molecules Gone Bad
Moderator, Laurie Kilpatrick, PhD, Children's Hospital of Philadelphia, Philadelphia, PA
The innate immune system is comprised of phagocytic cells such as neutrophils and monocytes which are the first line of defense against invading microorganisms. Inflammation triggers the activation of multiple proinflammatory pathways leading to the production of potent mediators such as TNF, C5a, oxygen radicals, NO and lipid metabolites. These mediators are important elements of host defense, but if not adequately regulated may also precipitate host tissue destruction associated with systemic inflammation. The inappropriate release of these mediators and subsequent damage to host tissue has been variously referred to as "an injury from within", "friendly fire injury" or "self-destructive bystander reaction". The focus of this workshop is on recent studies, which further define the role of these mediators in host tissue destruction and the regulatory mechanisms that control these potentially lethal mediators.
1:30-1:55 PMTNF Signaling in the Neutrophil: Friend or Foe?
Laurie Kilpatrick, PhD, Children's Hospital of Philadelphia, Philadelphia, PA
1:55-2:20 PMA Protective Role for Lipoxins in the Airway
Bruce Levy, MD, Harvard Medical School, Boston, MA
2:20-2:45 PMGood Complement Gone Bad
Peter Ward, MD, University of Michigan, Ann Arbor, MI
2:45-3:10 PMUp to NO Good: The Janus-Faced Roles of Nitric Oxide in Physiological Regulation and Oxidative Stress
Jack Lancaster, PhD, University of Alabama at Birmingham, Birmingham, AL
3:10-3:30 PMPanel Discussion and Questions
3:30-5:45 PM
Salon ABCD
Mini-Symposia III: Mechanisms of Endotoxin Tolerance and Tissue Injury Papers 262-271
Moderators: William Law, PhD, University of Illinois at Chicago, Chicago, Il and Avadhesh Sharma, PhD, North Dakota State University
3:30-3:42 PMInduction of Endotoxin Tolerance (ET) in the Absence of TLR4. Paper 262
Wyrta Heagy, Northwestern University, Chicago, IL.
3:42-3:54 PMUpregulation of Soluble TNF Receptor 1 (sTNFR1) Response to LPS During the Development of Endotoxin Tolerance. Paper 263
Daniel R.Meldrum, Indiana University Medical Center, Indianapolis, IN
3:54-4:06 PMExtracellular HSP-70: Potential Role in Endotoxin Tolerance. Paper 264
Rajesh Aneja, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
4:06-4:18 PMLipoproteins Play a Regulatory Role in the Hepatic and Systemic Response to Endotoxin. Paper 265
F. Behzad Kasravi, University of California San Francisco, San Francisco, CA
4:18-4:30 PMLiver Sinusoidal Endothelial Cells Respond Directly to LPS, Possibly via Toll-Like Receptor 4 (TRL4). Paper 266
Nicole Kresge, University of North Carolina Charlotte, Charlotte, NC
4:30-4:42 PMModulation of Endothelial Cell Activation by Bacterial Peptidoglycan-Associated Lipoprotein (PAL) Paper 267
Judith Hellman, Massachusetts General Hospital, Boston, MA
4:42-4:54 PMLPS Modulates Expression of Syndecan-1 and Bacterial Internalization by Enterocytes. Paper 268
Michelle J. Henry-Stanley, University of Minnesota, Minneapolis, MN.
4:54-5:06 PMThe Differential Compartmentalization of CXC Chemokines Facilitates Neutrophil Recruitment in Response to Intra-Pulmonary Endotoxin. Paper 269
Lee J. Quinton, Louisiana State University Health Sciences Center, New Orleans, LA
5:06-5:18 PMAlpha-Chemokine Receptor Inhibitor Reduces HMGB-1 Induced Acute Lung Injury. Paper 270
Edmund J. Miller, North Shore-LIJ Research Institute. Manhasset, NJ
5:18-5:30 PMReversing Established Sepsis with Antagonist of HMGB1. Paper 271
Huan Yang, North Shore LIJ Research Institute, Manhasset, NY.
3:30-5:30 PM
Salon EF
Mini-Symposia IV: Immune Modulation and Apoptosis in Sepsis and Burn Injury Papers 272-281
Moderators: Leona Rubin, PhD, University of Missouri, Columbia, MO and Stephen B. Jones, PhD, Loyola University of Chicago School of Medicine
3:30-3:42 PMBone Marrow Monocyte Production is Markedly Enhanced in Mice Genetically Devoid of Endogenous Catecholamines. Paper 272
Stephen B. Jones, Loyola University Medical Center, Maywood, IL.
3:42-3:54 PMDifferential Regulation of Neutrophil Cytokine Production During Sepsis by C5a. Paper 273
Niele.C. Riedemann, University of Michigan Medical School, Ann Arbor, MI.
3:54-4:06 PMTemperature Dependent Changes in PMN Respiratory Burst Depend on Altered Store Operated Calcium Entry. Paper 274
Carl J. Hauser, UMDNJ New Jersey Medical School, Newark NJ.
4:06-4:18 PMAdvanced Age and Lymphocyte Function After Burn Injury. Paper 275
Elizabeth J. Kovacs, Loyola University Medical Center, Maywood, IL
4:18-4:30 PMb2 Microglobulin Knockout Mice are Resistant to Lethal Intraabdominal Sepsis. Paper 276
Edward R. Sherwood, University of Texas Medical Branch, Galveston, TX.
4:30-4:42 PMAdoptive Transfer of Apoptotic Splenocytes Worsens Survival While Adoptive Transfer of Necrotic Splenocytes Improves Survival in Sepsis. Paper 277
Isaiah R. Turnbull, Washington University School of Medicine, St. Louis, MO
4:42-4:54 PMMesenteric Lymph from Male Rats Induces Endothelial Cell Apoptosis in a New In Vivo Model. Paper 278
Qi Lu, UMDNJ-New Jersey Medical School, Newark NJ.
4:54-5:06 PMTrauma Suppression of Bone Marrow Progenitor Cells is Prevented by Anti-Apoptotic Agents Both in Humans and Rats Paper 279.
Ziad.C. Sifri, UMD, New Jersey Medical School, Newark, NJ
5:06-5:18 PMThe Identification of Anti-Apoptotic Factors in NF-kB Mediated Apoptosis Inhibition in the Heart. Paper 280
Deborah L. Carlson, University of Texas, Southwestern Medical Center, Dallas, TX.
5:18-5:30 PMMAPK Regulation of Post-Ischemic Myocardial Apoptosis Paper 281
Theodore A. Christopher, Thomas Jefferson University, Philadelphia, PA
6:30-7:30 PM
West Courtyard
Reception
7:30-9:30 PM
Salon GHIJ
Dinner/Scientific Achievement & Service Awards Ceremony

Conference Registration: Registration fees admit members, non-members and students@ to scientific sessions, social functions including the opening reception, coffee breaks and all meals except on the free afternoon (Monday lunch and dinner). Registration as spouse/guest permits a guest or spouse of the participant to attend meal and social functions at cost to the Society. This is a social registration - to be admitted to a scientific session you MUST be registered as a participant.

Registration Form

Student registrants must have a department head or research advisor certify student's eligibility. If registering at the meeting bring a student ID card or letter signed by your department head/advisor.

Meeting site: Pointe Hilton Tapatio Cliffs Resort, Phoenix, Arizona is approximately 20 minutes north of the Phoenix, Sky Harbor Airport. Accommodations: (each includes a two-room suite) whether in the main resort building or cliff side, features a spacious living room with executive work desk, conversation area, two dual-line telephones with dataports, and refrigerated minibar. Reservations can be made by fax (602) 870-2797 or by phone - Call reservation manager at 800-876-4683. NOTE: You will need to indicate that you are with the Shock Society to receive the special group rate and should be made by May 5, 2003 to guarantee rates ($135 for single or double).

Hotel Registration

Travel arrangements: Phoenix Sky Harbor International Airport is served by 21 airlines, which provide nonstop service from Phoenix to 104 cities in the U.S. and around the world. America West Airlines and Southwest Airlines have major hub operations in Phoenix providing convenient connections to virtually any city in the U.S. Nonstop international service is provided by Aeromexico (to/from Mexico), British Airways (to/from London - Gatwick Airport), Lufthansa German Airlines (to/from Frankfurt, Germany), Air Canada (to/from Toronto and Calgary), and America West Airlines (to/from Canada and Mexico). The Pointe Hilton Tapatio Cliffs Resort is just 20 minutes from the airport.

Ground Transportation: Taxi, Van & Limo Transportation Phoenix Sky Harbor International Airport offers a variety of transportation options. Three taxi companies have contracted with Sky Harbor Airport to provide service to travelers for the following rates. There are no extra charges for more than one in the party or for baggage. You may choose any taxi you wish from the waiting line. The three companies are: AAA Cab (602) 437-4000, Allstate (602) 329-1017 and Discount (602) 266-1110. First Mile - $3.00, additional mile - $1.50 - airport surcharge $1.00.
Super Shuttle, operates 24 hours a day van service on a time scheduled basis. Vans depart to all areas of the Valley from 9 a.m. to 9 p.m. with lesser frequencies from 9 p.m. to 9 a.m. Fares are charged on a flat rate to each sector of geographic area. Call (602) 244-9000/voice or (602) 243-7786/TDD, for reservations. Super Shuttle Rate Information - Singe $10-$35.00 - Additional Person - $6.00
Unscheduled limousines offer airport-to-door service. Their rates include one or two in a party to the same address. The rate for three or more in one party to the same address is $7 for each additional passenger. Passengers are free to negotiate with the drivers for a lower rate, especially if the person waits for other passengers to load who will "share the fare."

Runners: Don't forget the 21st Annual Shock Society Presidential 5K Run
Race Registration

Details: For further information on the program, hotel, travel arrangements, 5-K run or conference registration contact Strategem, Inc. to obtain a complete program book (address below) or download it here (WordPerfect format, if you have problems downloading this then right-click the link and choose "Save Target As...").

We look forward to seeing you in Phoenix in June 2003.

Kathleen H. McDonough, Scientific Program Chair
(504) 568-6197
kmcdon@lsuhsc.edu

SHOCK 2003
C/o Strategem, Inc.
P.O. Box 1187
26064 Capital Drive - Suite A
Daphne, AL 36526
Fax: 334-625-4439
E-mail: curcur.msn.com


The Shock Society would like to thank the following companies for their generous sponsorship of this year's meeting.

Meeting Sponsor:

Aventis Behring

Pfizer

Major Sponsors:

Office of Naval Research

Baxter-Healthcare

Sponsors

Cubist Pharmaceuticals

HyCult Biotechnology b.v.

SHOCK SOCIETY TRAVEL AWARDS

Please join the Society in congratulating the following recipients of the 2003 Shock Society Travel Awards.
The session in which they will be presenting and their abstract numbers are listed below:

NEW INVESTIGATOR AWARD SESSION:

HongKuan Fan, PhD - The Medical University of South Carolina, Charleston, (Paper 72)
Kinga Powers, MD - University of Toronto, Toronto, Ontario, Canada (Paper 73)
Zhihong Hu, MD - Loyola University Medical Center, Chicago, Il (Paper 76)

POSTER SESSION I

Preya Ananthakrishnan, MD - UMDJN-New Jersey Medical School, Newark NJ (Paper 12)
Katherine Barness, MD - University of Colorado, Denver, CO (Paper 39)
Konstantin Umanskiy, MD - University of Cincinnati, Cincinnati, OH (Paper 47)
Dirk Henrich, Dr. phil.nat. - JW-Goethe University, Frankfurt, Germany, (Paper 52)
Octavia Peck - The Medical University of South Carolina, Charleston, SC (Paper 67)

POSTER SESSION II

Xiaoxuan Cui, MD,PhD - North Shore-Long Island Jewish Medical Center, Manhasset, NY (Paper 99)
Rongqian Wu, MD, PhD - North Shore Long Island Jewish Medical Center, Manhasset NY (Paper 126)
David Cohen, MD - New Jersey Medical School, Newark, NJ (Paper 138)
Claudio Lagoa, DVM - University of Pittsburgh, Pittsburgh, PA (Paper 150)
David Santone - Toronto General Hospital, Toronto, Ontario, Canada, (Paper 162)
Alia Shah - University of Texas Medical Branch, Galveston, Galveston, TX (Paper 163)
Albert Swafford - Louisiana State University Health Sciences Center, New Orleans, LA (Paper 167)
Hiroyuki Tanaka, PhD - University of Pittsburgh, Pittsburgh, PA (Paper 168)
Hiroyuki Tanaka, PhD - University of Pittsburgh, Pittsburgh, PA (Paper 168)

POSTER SESSION III

Niamh Choileain - Harvard Medical School, Boston, MA (Paper 179)
Jennifer Rietfors - University of California San Diego, San Diego, CA (Paper 191)
Forest Sheppard, MD - UCHSC and DHMC, Denver, CO (Paper 192)
Bashir Attuwaybi, MD - University of Texas, Houston, TX (Paper 194)
Joanne Lomas - University of Rhode Island/Rhode Island Hospital, Providence RI (Paper 197)
John Cha, MD - University of Colorado Health Sciences Center, Denver CO, (Paper 233)

MINI SYMPOSIUM I

Mark Lehnert, MD - University of North Carolina, Chapel Hill, NC (Paper 81)

 

 

INVESTIGATORS PARTICIPATING IN THE NEW INVESTIGATOR COMPETITION

HongKuan Fan, PhD - The Medical University of South Carolina, Charleston, (Paper 72)
Kinga Powers, MD - University of Toronto, Toronto, Ontario, Canada (Paper 73)
Kareem D. Husain, MD - Washington University School of Medicine, St. Louis, MO (Paper 74)
Virginia Vega - Johns Hopkins University School of Medicine, Baltimore, MD (Paper 75)
Zhihong Hu, MD - Loyola University Medical Center, Chicago, Il (Paper 76)

Valid XHTML 1.0! Valid CSS!